Influenza vaccines in children

Seminars in Pediatric Infectious Diseases

Volumn 13, Issue 3, 2002, Pages 174-181

  Neuzil, Kathleen M ^a   Edwards, Kathryn M ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; LIVE VACCINE; TRIPLE VACCINE; INACTIVATED VACCINE;

ARTICLE; ASTHMA; BRONCHOSPASM; CLINICAL TRIAL; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; HIGH RISK POPULATION; HUMAN; IMMUNOGENICITY; INFECTION PREVENTION; INFECTION RISK; INFLUENZA; INFLUENZA VACCINATION; SEROCONVERSION; TREATMENT INDICATION; CHILD; IMMUNOLOGY; INFANT; INTRANASAL DRUG ADMINISTRATION; METHODOLOGY; ORTHOMYXOVIRUS; PRESCHOOL CHILD; REVIEW; STANDARD; VACCINATION;

ADMINISTRATION, INTRANASAL; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; INFLUENZA VACCINES; INFLUENZA, HUMAN; ORTHOMYXOVIRIDAE; VACCINATION; VACCINES, ATTENUATED; VACCINES, INACTIVATED;

EID: 0036628938     PISSN: 10451870     EISSN: None     Source Type: Journal    
DOI: 10.1053/spid.2002.125860     Document Type: Article

References (52)

1. Mortality from influenza
2. Epidemiologic studies of Asian influenza in a Louisiana parish
3. Emerging infections: Pandemic influenza
4. Influenza A infections in young children. Primary natural infection and protective efficacy of live-vaccine-induced or naturally acquired immunity
5. Influenza virus infections in infants
6. Age distribution of patients with medically-attended illnesses caused by sequential variants of influenzaA/HINI; comparison to age-specific infection rates, 1978-1979
7. Interpandemic influenza in the Houston area, 1974-76
8. The impact of influenza on hospitalizations, outpatient visits and antibiotic prescriptions in children
9. The burden of interpandemic influenza in children younger than 5 years: A 25-year prospective study
10. Influenza and the rates of hospitalization for respiratory disease among infants and young children
11. Winter viruses: Influenza and respiratory syncytial virus-related morbidity
12. Impact of type A influenza on children: A retrospective study
13. The burden of influenza illness in children with asthma and other chronic medical conditions
14. Influenza A and B virus infection in infants and young children during the years 1957-1976
15. Severe pneumococcal pneumonia in previously healthy children: The role of preceding influenza infection
16. Bacterial adherence to pharyngeal cells during viral infection
17. Association of invasive pneumococcal disease with season, atmospheric conditions, air pollution, and the isolation of respiratory viruses
18. Influenza virus infections in Seattle families, 1975-1979
19. Estimating household and community transmission parameters for influenza
20. Influenza in the family
21. Effectiveness of influenza vaccination of day care children in reducing influenza-related morbidity among household contacts
22. Influenza vaccination in children with asthma in Health Maintenance Organizations
23. Influenza vaccine for children with asthma: Why no progress?
24. Prevention and control of influenza
25. Influenza
26. Predictors of influenza virus vaccination status in hospitalized children
27. Comparison of heterotypic protection against influenza A/Taiwan/86 (HINI) by attenuated and inactivated vaccines to A/Chile/83-like viruses
28. Live attenuated and inactivated influenza vaccine in school-age children
29. Influenza in children: Epidemiology, immunity and vaccines
30. The efficacy of inactivated and cold-adapted vaccines against influenza A infection, 1985-1990: The pediatric experience
31. Effect of prednisone on response to influenza virus vaccine in asthmatic children
32. Influenza vaccination of children during acute asthma exacerbation and concurrent prednisone therapy
33. The safety of inactivated influenza vaccine in adults and children with asthma
34. Influenza vaccination in the prevention of acute otitis media in children
35. Influenza A vaccine decreases the incidence of otitis media in 6- to 30-month-old children in day care
36. Studies of the 1996-97 inactivated influenza vaccine among children attending day care
37. Efficacy of inactivated vaccine in preventing antigenically drifted influenza type A and well-matched type B
38. Secretory and systemic immunological response in children infected with live attenuated influenza A virus vaccines
39. Comparison of US inactivated split-virus and Russian live attenuated, cold-adapted trivalent vaccines in Russian schoolchildren
40. Mucosal immune response to trivalent live attenuated intranasal influenza vaccine in children
41. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenza-virus vaccine in children
42. Efficacy of vaccination with live-attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine
43. Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza vaccine
44. Large scale safety study of Flumist in 9,689 children 1-17 years of age
45. Comparison of live, attenuated HINI and H3N2 cold-adapted and avian-human influenza A reassortant viruses and inactivated virus vaccine in adults
46. Immunity to influenza A virus infection in young children: A comparison of natural infection, live cold-adapted vaccine, and inactivated vaccine
47. Modification of an outbreak of influenza in Tecumseh, Michigan by vaccination of school children
48. The Japanese experience with vaccinating schoolchildren against influenza
49. Economic impact of influenza vaccination in preschool children
50. Is it time to give influenza vaccine to healthy infants?
51. Delayed vaccine availability for 2001-02 season and supplemental recommendations by the Advisory Committee on Immunization Practices
52. Influenza and pneumococcal vaccination levels among persons aged ≥ 65 years - United States, 1999